BELKYRA Solution for injection Ref.[7699] Active ingredients: Deoxycholic acid

Source: Health Products Regulatory Authority (IE)  Revision Year: 2019  Publisher: Allergan Pharmaceuticals International Limited, Clonshaugh Business & Technology park, Dublin 17, D17 E400, Ireland

Product name and form

Belkyra 10mg/ml solution for injection.

Pharmaceutical Form

Solution for injection (injection).

A clear, colourless solution, free from visible particles.

The formulation is adjusted to pH 8.3 with hydrochloric acid or sodium hydroxide and has a tonicity compatible with that of biological tissues and fluids at an osmolality of 300 mOsm/kg.

Qualitative and quantitative composition

1 ml solution for injection contains 10 mg deoxycholic acid.

Each vial contains 20 mg of deoxycholic acid in 2 ml solution.

Excipient(s) with known effect: Each mL contains 184 ยตmol (or 4.23 mg) of sodium from sodium chloride, sodium hydroxide and disodium phosphate anhydrous.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Deoxycholic acid

Deoxycholic acid is a cytolytic drug, which when injected into localized subcutaneous fat, physically disrupts the cell membrane of adipocytes. The destruction of adipocytes elicits a tissue response in which macrophages are attracted to the area to eliminate cellular debris and lipids, which are then cleared through natural processes.

List of Excipients

Water for injection
Sodium chloride
Sodium hydroxide (for dissolution and pH adjustment)
Disodium phosphate anhydrous
Hydrochloric acid (for pH adjustment)

Pack sizes and marketing

Solution for injection in a vial (Type I glass), fitted with a stopper (chlorobutyl rubber) and a seal (aluminium) with flip-top lid (polypropylene).

One carton contains 4 vials. Each vial contains 2 ml solution for injection.

Marketing authorization holder

Allergan Pharmaceuticals International Limited, Clonshaugh Business & Technology park, Dublin 17, D17 E400, Ireland

Marketing authorization dates and numbers

PA2103/003/001

Date of first authorisation: 2nd June 2017

Drugs

Drug Countries
BELKYRA Austria, Brazil, Canada, Estonia, Spain, Finland, Hong Kong, Ireland, Lithuania, Malta, New Zealand, Poland, Romania, Singapore, United Kingdom

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.